Pancreatic Cancer Trial, Recruiting (NCT03492151)

Pancreatic Cancer Trial, Recruiting NCT03492151 Sponsor: Ohio State University Comprehensive Cancer Center Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03492151 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been referred for a specific type of ultrasound-guided biopsy procedure (called EUS-FNA) to examine a fluid-filled sac (cyst) on your pancreas, and surgery is being considered
Your pancreatic cyst measures at least 2.0 cm (about the size of a small grape) based on previous scan results such as a CT or MRI

Who may not be able to join:

You are not able to give informed consent to take part in the study
You are not able to tolerate or safely undergo the procedure
You are pregnant at the time of the procedure
You are under 18 years of age
You have a condition that affects your blood's ability to clot properly (confirm with trial site)
You have a known allergy to a dye called fluorescein
You have previously been diagnosed with pancreatic cancer
You have previously had surgery on your pancreas

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Somashekar Krishna, MD, MPH, Ohio State University

Phone: 614-293-1056

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03492151

Sponsor: Ohio State University Comprehensive Cancer Center

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: 614-293-1056

More information: https://clinicaltrials.gov/study/NCT03492151

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been referred for a specific type of ultrasound-guided biopsy procedure (called EUS-FNA) to examine a fluid-filled sac (cyst) on your pancreas, and surgery is being considered
Your pancreatic cyst measures at least 2.0 cm (about the size of a small grape) based on previous scan results such as a CT or MRI

Who may not be able to join:

You are not able to give informed consent to take part in the study
You are not able to tolerate or safely undergo the procedure
You are pregnant at the time of the procedure
You are under 18 years of age
You have a condition that affects your blood's ability to clot properly (confirm with trial site)
You have a known allergy to a dye called fluorescein
You have previously been diagnosed with pancreatic cancer
You have previously had surgery on your pancreas

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ohio State University Comprehensive Cancer Center

Registry

ClinicalTrials.gov

Start date

1 October 2018

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Accuracy of PCL diagnosis; Accuracy of risk-stratification of IPMNs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov